Marks Group Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
|
|||||
|
2025
Q1 | $1.27M | Sell |
|
|||||
|
2024
Q4 | $1.65M | Buy |
|
|||||
|
2024
Q3 | $2.25M | Sell |
|
|||||
|
2024
Q2 | $2.7M | Sell |
|
|||||
|
2024
Q1 | $2.56M | Sell |
|
|||||
|
2023
Q4 | $2.12M | Buy |
|
|||||
|
2023
Q3 | $1.85M | Sell |
|
|||||
|
2023
Q2 | $1.74M | Buy |
|
|||||
|
2023
Q1 | $1.39M | Buy |
|
|||||
|
2022
Q4 | $1.18M | Buy |
|
|||||
|
2022
Q3 | $832K | Sell |
|
|||||
|
2022
Q2 | $952K | Sell |
|
|||||
|
2022
Q1 | $1.36M | Buy |
|
|||||
|
2021
Q4 | $1.14M | Buy |
|
|||||
|
2021
Q3 | $552K | Buy |
|
|||||
|
2021
Q2 | $200K | Buy |
|